Your browser doesn't support javascript.
loading
[What's new in internal medecine?] / Quoi de neuf en médecine interne ?
Jachiet, M; Rybojad, M; Bouaziz, J-D.
Afiliación
  • Jachiet M; Service de dermatologie, hôpital Saint-Louis, INSERM U976, université Paris-Diderot-Paris VII, Sorbonne-Paris-Cité, Paris, France.
  • Rybojad M; Service de dermatologie, hôpital Saint-Louis, INSERM U976, université Paris-Diderot-Paris VII, Sorbonne-Paris-Cité, Paris, France.
  • Bouaziz JD; Service de dermatologie, hôpital Saint-Louis, INSERM U976, université Paris-Diderot-Paris VII, Sorbonne-Paris-Cité, Paris, France. Electronic address: jean-david.bouaziz@aphp.fr.
Ann Dermatol Venereol ; 143 Suppl 3: S23-S28, 2016 Dec.
Article en Fr | MEDLINE | ID: mdl-29429506
ABSTRACT
Answering the question « what's new in internal medecine in 2016? ¼ is very challenging. We used 3 methods of article selection to reduce the selection bias 3 authors, a systematic review of the articles discussed in the weekly bibliographic meeting of our unit (Dermatology department, Saint-Louis Hospital, Paris, France) and a selection of the best articles by several internal medecine practitioners in Paris. Eleven « hot topics ¼ were analyzed i/lowering cholesterol level but not blood blessure has a significant impact on cardiovascular morbi-mortality in cardiovascular intermediate risk patients; ii/the « treat to treat target ¼ is efficient in psoriatic arthritis; iii/ a genotype/ phenotype correlation favors the separation of ileal Crohn's disease, colonic Crohn's disease and ulcerative colitis; iv/ tocilizumab treatment (anti-IL-6 monoclonal antibody ) is very efficient in giant cell arteritis and slightly efficient in systemic sclerosis; v/ combination therapy using methotrexate plus steroids compared with steroids alone becomes the « gold standard ¼ treatment for juvenile dermatomyositis; vi/ dupilumab treatment (antibody blocking IL-4 and IL-13 receptors) is not only efficient in atopic dermatitis but also in asthma; vii/ think of eosinophilic oesophagitis in a patient with atopic dermatitis and dypshagia or food impaction; viii/ genetic A2 protein dysfunction induces NF-kB hyperactivation and an autoinflammatory disorder with features similar to Behcet's disease; ix/ no new biotherapies have shown high efficacy in systemic lupus erythematosus; x/ nanoparticles loaded with autoantigens induce Tregs and Bregs and may be a promising therapeutic option to treat auto-immune disease in the future; xi/ ipilimumab treatment (anti-CTLA4 antibody, immune checkpoint inhibitor) may induce complete remission in acute myeloid leukemia patients relapsing after haematological stem cell transplantation. Year 2016 is full of great discoveries in internal medicine keeping the dermatologist brain fully open minded.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Medicina Interna Tipo de estudio: Systematic_reviews Límite: Humans Idioma: Fr Revista: Ann Dermatol Venereol Año: 2016 Tipo del documento: Article País de afiliación: Francia Pais de publicación: FR / FRANCE / FRANCIA / FRANÇA

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Medicina Interna Tipo de estudio: Systematic_reviews Límite: Humans Idioma: Fr Revista: Ann Dermatol Venereol Año: 2016 Tipo del documento: Article País de afiliación: Francia Pais de publicación: FR / FRANCE / FRANCIA / FRANÇA